Update wiki/pages/attributions.html, wiki/pages/human-practices.html

wiki/pages/attributions.html

@@ -29,6 +29,7 @@ Wet Team Mentor: Dr. Lu Dayun, Xiang Xincheng
   <div class="article-content "> ● Kr Space</div>
   <div class="title">Human Practice Support</div>
   <div class="article-content ">
+    ● Wang Qingzhuo, associate professor, Nanjing University of Traditional Chinese Medicine; PhD. Molecular Plant Innovation Center of Chinese Academy of Sciences.<br/>
     ● LU CHENG, chief pharmacist, Wuhan Institute of Technology Hospital<br />
     ● Manager KE, fish farming expert, Shanghai Haichang Ocean Park<br />
     ● Ms. LAN, Business Plan advisor <br />

wiki/pages/human-practices.html

@@ -22,10 +22,7 @@
     received online.<br />
     To have a deeper understanding of how the stakeholders think about our product, we paid a trip to Haichang Ocean
     Park and talked to the breeding technician, Mr. Ke.<br />
-    Besides, we also look for professional insights. So we interviewed Dr. Wang, who studies antimicrobial peptides, and
-    fully understands the suggestions and precautions for the design and application of antimicrobial peptides products
-    and Antibiotic Specialist Director Lu Cheng understands the prospects and safety of the antimicrobial peptide
-    products.
+    Besides, we also sought professional insights on our project from two experts through online meetings. From Prof. Wang, who is an associate professor from Nanjing University of Traditional Chinese Medicine, we learned more about antimicrobial peptides in the synthetic biology view, including its application and many technical advice on the product implementation; From Doctor Lu, we acquired many information regarding the prospects and safety of the antimicrobial peptide products.
   </div>
   <div class="article-content margin-top-45 margin-bottom-45">Below is the mind map of our Integrated Human Practice:
   </div>
@@ -227,10 +224,10 @@
     3. There are harmful bacteria and beneficial bacteria in the water, so we can use a variety of antibacterial
     peptides combined to eliminate specialiy fungicidal and antibacter to protect beneficial bacteria .
   </div>
-  <div class="title">Part 4 Interview with Director Lu Cheng</div>
+  <div class="title">Part 4 Interview with Pharmacist Lu Cheng</div>
   <div class="img-wrap no-margin">
     <img class="w-80" src=" https://static.igem.wiki/teams/4248/wiki/t-shanghai-city-human-practices08.png" />
-    <span>Graph 8. Virtual interview with Dr. Lu who joined the meeting by telephone</span>
+    <span>Graph 8. Virtual interview with doctor Lu who joined the meeting by telephone</span>
   </div>
   <div class="article-content ">On July.7, dry lab interviewed doctor Lu Cheng in order to understand the side effects
     of current clinical use of antibiotics, the future of antibiotics, and the possibility of using antimicrobial
@@ -310,8 +307,7 @@
   <div class="article-content ">
     In the clinical trial stage,antimicrobial peptides has no effect on normal cells. Compared with antibiotics, The
     advantage of antimicrobial peptides are natural active substances, mostly composed of 20-60 amino acids, including
-    antibacterial, antifungal, and antibacterial <br />
-    viruses and other different roles are ideal alternatives to antibiotics
+    antibacterial, antifungal, and antibacterial viruses and other different roles are ideal alternatives to antibiotics
   </div>
   <div class="title">Part 5. Interview with Professor Wang</div>
   <div class="img-wrap no-margin">
@@ -319,7 +315,7 @@
     <span>Graph 9. Virtual Interview with Prof. Wang</span>
   </div>
   <div class="sub-title">Part 5.1 The Introduction of our interview:</div>
-  <div class="article-content ">At the beginning of the project, we interviewed Dr. Wang, who is currently working at
+  <div class="article-content ">At the beginning of the project, we interviewed Professor Wang, who is currently working at
     the Shanghai Institute of Biological Sciences, about the current status and prospects of antimicrobial peptides.
     Before the interview, we were worried about the current development of antimicrobial peptides and wondered what our
     team could do to achieve the purpose of promoting market development.</div>